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The Use of Complementary and Alternative Medicine is
Frequent in Patients With Pancreatic Disorders
Serena Stigliano, MD, Livia Archibugi, MD, Giulia Zerboni, MD,
Gianfranco Delle Fave, MD, and Gabriele Capurso, MD, PhD
Background: Herbal remedies and other complementary and
alternative medicine (CAM) are used by 30% of the patients with
liver and inflammatory bowel diseases. However, there are no data
regarding CAM use in patients with pancreatic disorders, including
potential pancreatotoxicity.
Aim of the Study: The aim of the study was to assess the prevalence
of CAM use in patients with pancreatic disorders and screen for
pancreatotoxicity.
Materials and Methods: This was a cross-sectional survey of con-
secutive outpatients seen at a Pancreas Center. Data were collected
in a specific questionnaire. Descriptive statistics were used to
analyze the prevalence and the patterns of CAM use. Character-
istics associated with CAM use were analyzed by appropriate
statistics.
Results: Of 108 patients (52% male; mean age, 65±13 years), 47
(43.5%) used CAM. The use of CAM was more frequent among
patients with previous acute pancreatitis (47%). Reported reasons
for the use of CAM were to help standard therapies and for an
overall better feeling. About 61% of the patients reported advan-
tages with treatment. As compared with nonusers, CAM users were
more often female (55% vs. 42%), with a higher school degree
(43% vs. 36%), more frequently performing physical activity (51%
vs. 41%), and reporting anxiety (45% vs. 31%). However, none of
these differences were statistically significant. Three patients with
previous acute pancreatitis reported the use of Serenoa repens that
is potentially pancreatotoxic.
Discussion: The rate of CAM use in patients with pancreatic dis-
orders is similar to those reported for other digestive diseases.
CAM use seems to be more frequent in women with a higher
education level and a “healthier lifestyle.” Patients might not be
aware of the potential pancreatotoxicity of CAM, which should be
carefully considered by physicians.
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Herbal remedies and other complementary and alter-native medicine (CAM) are frequently used for the
management of various conditions including health main-
tenance, management of anxiety, obesity, diabetes, rheu-
matologic illness, cancer, cardiovascular disease, and other
chronic disorders including those of the gastrointestinal
tract.1
According to the National Institutes of Health, CAM
are defined as a group of diverse medical and health care
systems, practices, and products that are not presently
considered to be part of conventional medicine.2
The use of CAM has become widespread among
people with chronic disease, as it promotes greater personal
control over the health decision, empowers people to
manage their chronic condition, and helps avoid the dis-
satisfaction often associated with conventional health care.
CAM are often considered by individuals using them
to be safer than the standard medical practice because they
are “natural” or are based on a concept of “wellness” and
health.3
Previous studies showed that the prevalence of CAM
usage ranges from 21 to 60% in patients with inflammatory
bowel4 and from 20% to 50%1,5 in patients with chronic
liver disease.
In these previous studies, the most common reason for
CAM usage was dissatisfaction with conventional therapy.6
CAM use seemed more frequent in female patients7 and in
particular in those with high incomes and a high educa-
tional level.5
Despite increasing popularity, communication about
the use of CAM between physicians and patients is limited,
as most physicians know little about CAM and patients
avoid discussing about CAM because of the fear of the
doctor’s disagreement.3
Using CAM therapies may be beneficial, but such
therapies can also interact with the conventional medi-
cations. Most alarmingly, some products may have serious
adverse effects, resulting in, for example, a deterioration of
the liver function.8
Although there are different studies evaluating the
prevalence of CAM usage in various chronic gastro-
intestinal diseases, there are no data regarding CAM usage
in patients with pancreatic disorders. In addition, the lack
of information is associated with the unawareness of their
potential pancreatotoxicity.
AIM
The primary aim of this study was to assess the
prevalence of CAM usage in patients with various pancre-
atic disorders. A secondary aim was to screen the possible
pancreatotoxicity of these products.
MATERIALS AND METHODS
A cross-sectional study was conducted at a pancreatic
disorders outpatient clinic over a 6-month time frame.
Consecutive patients with pancreatic disorders were
included.
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Data were collected by a trained doctor using a
questionnaire regarding demographics and clinical infor-
mation, CAM usage, and reported reasons for it, the length
of usage, and perceived experiences of CAM efficacy. Each
participant was also interviewed about their life style, level
of education, and current employment status to elicit other
relevant exposures. Patients gave an informed consent and
the study received local ethic committee approval.
Categorical variables were analyzed by means of the
Fisher test and continuous variables expressed by mean±
SEM were examined by the Student t test. A P<0.05 was
considered significant. A dedicated software (MedCalc,
Mariakerke, Belgium) was used throughout the study.
RESULTS
One hundred eight consecutive patients were enrolled
(52% male; mean age, 65 y±13).
The most common reason for the visit at the Pancre-
atic Disorders Clinic was intraductal papillary mucinous
neoplasm (44 patients, 40.7%), followed by previous acute
pancreatitis (AP) (34, 31.5%), chronic pancreatitis (20,
19%), with other less common disorders such as pancreatic
cancer or other cystic lesions in 10 patients (9.2%).
Forty-seven of the 108 patients (44%) reported the use
of CAM: 14 of these 47 (29.8%) patients have used CAM for
>12 months. The mean age of the “CAM users” was
64±13 years, and the majority of them (55.3%) were female.
The most frequent reason reported by patients for the
use of CAM was to “help standard therapies” (14, 29.7%)
and for an “overall better feeling” (12, 25.5%). About
61.7% of the patients reported to have perceived some
advantages with treatment.
Only 4% of the patients who used CAM thought that
these products could interfere or interact with the conven-
tional drugs. Furthermore, 28% of them did not commu-
nicate the usage of CAM to their primary-care physician or
to other doctors taking care of them.
CAM users more often reported having a high-school
or a university degree (44% vs. 36% of nonusers; P=0.43)
and performing physical activity more than once a week
(43% vs. 34%; P=0.43), and were less frequently over-
weight (body mass index>25 46.8% vs. 54%; P=0.56).
Regarding other medical disorders, CAM users reported
osteomuscular pain (59.6% vs. 44,3%; P=0.13), anxiety
(45% vs. 31%; P=0.23), and symptoms suggestive of
irritable bowel syndrome (17% vs. 9.8%; P=0.38) more
frequently as compared with patients not using CAM.
However, these differences were not statistically significant
(Table 1).
Concerning the category of CAM, 28% of the 47
CAM users reported the use of herbal remedies, 11% the
use of vitamins, 9% minerals, and 47% other nutritional
supplements (Table 2).
Regarding the reason for the outpatient visit, the
highest rate of CAM users was observed among patients
with a previous episode of AP (16/34, 47%), followed by
41% (18/44) in patients with intraductal papillary mucinous
neoplasm and 35% (7/20) in patients with chronic
pancreatitis.
We also screened the exact composition of the products
used for their potential pancreatotoxicity. Interestingly, 3
patients who had previous idiopathic AP have used products
composed of Serenoa repens, a substance that has been dem-
onstrated to be associated with pancreatotoxicity before.9,10
DISCUSSION
In the last decades, the use of herbal remedies and
other nonconventional therapy has increased substantially
and has become a factor possibly concerning the manage-
ment of various chronic gastrointestinal diseases.2,5
Previous studies have demonstrated that the use of
these products is common in patients with inflammatory
bowel disease and chronic liver disease,3,4 but there are no
data about the prevalence of CAM usage in patients with
pancreatic disorders.
We conducted a cross-sectional survey in patients with
various pancreatic disorders to assess the rate of usage of
these products and to screen for their potential
pancreatotoxicity.
Our data showed that 44% of the patients with pan-
creatic disorders used CAM, a percentage that is similar to
or higher than those reported for other chronic gastro-
intestinal disorders.
CAM usage was more frequent in patients with pre-
vious AP, and in particular, it seemed to be more common
in patients with previous idiopathic AP.
In keeping with findings of previous studies,7 in the
present study, CAM users were more frequently female,
with a higher education level and a “healthier lifestyle”
compared with nonusers, even if the differences were not
statistically significant.
The most common reason for CAM usage was to
“help standard therapy” and for an “overall better feeling.”
Only a small percentage of patients believed that CAM
could interfere with other conventional therapies and not
all of them reported the usage to their primary-care
physician.
TABLE 1. Demographic and Clinical Features of CAM Users and
Nonusers
n (%)
Characteristics
CAM Users
(47)
Non-CAM Users
(61) P
Sex (female) 26 (55.3) 26 (42.6) 0.24
Mean age (y) 64 66
High education
level
21 (44) 22 (36) 0.43
BMI<25 26 (55.3) 28 (45.9) 0.56
Smoking 10 (21.3) 17 (27.8) 0.51
Osteomuscular
pain
28 (59.6) 27 (44.3) 0.13
IBS symptoms 8 (17) 6 (9.8) 0.38
Anxiety 20 (42.6) 19 (31.2) 0.23
BMI indicates body mass index; CAM, complementary and alternative
medicine; IBS, irritable bowel syndrome.
TABLE 2. Most Frequent Categories of Products Used by the 47
Patients Taking CAM
Category of CAM No. Patients (%)
Herbal remedies 13 (28)
Vitamins 5 (11)
Minerals 4 (9)
Other nutritional supplements 22 (47)
CAM indicates complementary and alternative medicine.
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One might hypothesize that this is be because of the
general belief that herbal remedies and other nonconven-
tional drugs are safe and natural, and so they cannot have
any adverse effects.3
However, herbal medicines contain multiple active
ingredients that have the potential to be not only beneficial
but also harmful under a number of medical conditions.8
The effect of herbal medicines may not simply result
from the combination of various known active ingredients,
but the effect of unrecognized biologically active compo-
nents of a particular herbal preparation. Because of the
complexity of the chemical components and potential
actions, a comprehensive understanding of herbal drugs is
still challenging.8
There are few data about the potential toxic effects of
CAM on the pancreas. Two case reports showed a possible
AP induced by saw-palmetto, a plants that is commonly
used in drugs for the treatment of benign prostatic hyper-
trophy.9 This product had been used by 3 patients with
previous idiopathic AP in the present survey.
Notably, according to the present data, 45% of the
patients with a previous episode of idiopathic AP reported
the use of CAM. These data suggest that the use of
potentially pancreatotoxic CAM should be ruled out care-
fully during the diagnostic work-out of idiopathic AP.10
In conclusion, we report for the first time the high
prevalence of CAM usage in patients with pancreatic dis-
orders. Physicians should screen their use accurately
because patients may not be aware of the potential adverse
effects of CAM in this setting.
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